Connor, Clark & Lunn Investment Management (CC&L)’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $270K | Sell |
|
|||||
|
2017
Q3 | $307K | Buy |
|
|||||
|
2017
Q2 | $262K | Buy |
|
|||||
|
2017
Q1 | $153K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $156K | Hold |
|
|||||
|
2016
Q2 | $89K | Hold |
|
|||||
|
2016
Q1 | $121K | Hold |
|
|||||
|
2015
Q4 | $211K | Hold |
|
|||||
|
2015
Q3 | $260K | Buy |
|
|||||
|
2015
Q2 | $288K | Buy |
|
|||||
|
2015
Q1 | $121K | Buy |
|
|||||
|
2014
Q4 | $109K | Buy |
|
|||||
|
2014
Q3 | $52K | Buy |
|